Navinta Llc Company Profile
What is the competitive landscape for NAVINTA LLC
NAVINTA LLC has twenty-one approved drugs.
Summary for Navinta Llc
| US Patents: | 0 |
| Tradenames: | 20 |
| Ingredients: | 20 |
| NDAs: | 21 |
| Patent Litigation for Navinta Llc: | See patent lawsuits for Navinta Llc |
Drugs and US Patents for Navinta Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Navinta Llc | CARGLUMIC ACID | carglumic acid | TABLET, FOR SUSPENSION;ORAL | 213395-001 | Jun 22, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Navinta Llc | DIAZEPAM | diazepam | GEL;RECTAL | 217468-003 | Nov 14, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Navinta Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 078601-003 | Jul 17, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
